IL141221A0 - Urate oxidase - Google Patents

Urate oxidase

Info

Publication number
IL141221A0
IL141221A0 IL14122199A IL14122199A IL141221A0 IL 141221 A0 IL141221 A0 IL 141221A0 IL 14122199 A IL14122199 A IL 14122199A IL 14122199 A IL14122199 A IL 14122199A IL 141221 A0 IL141221 A0 IL 141221A0
Authority
IL
Israel
Prior art keywords
proteins
uricase
urate oxidase
relates
intermediates
Prior art date
Application number
IL14122199A
Other languages
English (en)
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of IL141221A0 publication Critical patent/IL141221A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C12N9/0048—Uricase (1.7.3.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y107/00—Oxidoreductases acting on other nitrogenous compounds as donors (1.7)
    • C12Y107/03—Oxidoreductases acting on other nitrogenous compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C12Y107/03003—Factor-independent urate hydroxylase (1.7.3.3), i.e. uricase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14122199A 1998-08-06 1999-08-05 Urate oxidase IL141221A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9548998P 1998-08-06 1998-08-06
PCT/US1999/017678 WO2000008196A2 (en) 1998-08-06 1999-08-05 Urate oxidase

Publications (1)

Publication Number Publication Date
IL141221A0 true IL141221A0 (en) 2002-03-10

Family

ID=22252247

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14122199A IL141221A0 (en) 1998-08-06 1999-08-05 Urate oxidase
IL141221A IL141221A (en) 1998-08-06 2001-02-01 Urate oxidase
IL197339A IL197339A (en) 1998-08-06 2009-03-02 Recombinant chimeric uricase protein, protein-containing linker and preparations containing them

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL141221A IL141221A (en) 1998-08-06 2001-02-01 Urate oxidase
IL197339A IL197339A (en) 1998-08-06 2009-03-02 Recombinant chimeric uricase protein, protein-containing linker and preparations containing them

Country Status (22)

Country Link
US (1) US7056713B1 (de)
EP (2) EP1100880B1 (de)
JP (3) JP2002524053A (de)
KR (1) KR100841634B1 (de)
CN (2) CN101280293B (de)
AT (1) ATE483797T1 (de)
AU (1) AU766421B2 (de)
BR (1) BRPI9913360B8 (de)
CA (1) CA2337967C (de)
CY (1) CY1111001T1 (de)
CZ (1) CZ304223B6 (de)
DE (1) DE69942834D1 (de)
DK (1) DK1100880T3 (de)
ES (1) ES2352451T3 (de)
HU (1) HU229774B1 (de)
IL (3) IL141221A0 (de)
NZ (1) NZ509633A (de)
PL (1) PL207369B1 (de)
PT (1) PT1100880E (de)
RU (1) RU2290439C2 (de)
WO (1) WO2000008196A2 (de)
ZA (1) ZA200100974B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100542B1 (de) * 1998-08-06 2005-06-22 Mountain View Pharmaceuticals, Inc. Peg-uricase konjugate und verwendung davon
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
US20060188971A1 (en) * 1998-08-06 2006-08-24 Duke University Urate oxidase
CA2337967C (en) * 1998-08-06 2011-11-01 Duke University Recombinant uricase protein
EP2158923B1 (de) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-uricase Konjugate und Verwendung davon
CN100371439C (zh) * 2003-04-07 2008-02-27 北京双鹭药业股份有限公司 一种重组假丝酵母尿酸氧化酶的制备方法
CN100334207C (zh) * 2004-04-27 2007-08-29 杭州北斗生物技术有限公司 一种黄曲霉尿酸氧化酶的制备方法
DK3321359T3 (da) * 2005-04-11 2021-03-08 Horizon Pharma Rheumatology Llc Variante former af uratoxidase og anvendelse deraf
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
AU2011257764B2 (en) * 2005-04-11 2012-04-05 Horizon Therapeutics Usa, Inc. A variant form of urate oxidase and use thereof
WO2008051178A2 (en) 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
CN102807973A (zh) * 2005-04-11 2012-12-05 萨文特医药公司 尿酸氧化酶的变体形式及其用途
CN101402688B (zh) * 2008-11-18 2011-04-20 中国人民解放军军事医学科学院生物工程研究所 一种融合蛋白及其编码基因与应用
WO2010110464A1 (en) 2009-03-24 2010-09-30 Meito Sangyo Co., Ltd. Improved type milk-clotting protease derived from a microorganism
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
CN102051348B (zh) * 2009-10-27 2012-10-03 重庆富进生物医药有限公司 人源化重组尿酸酶及其突变体
RU2460793C2 (ru) * 2010-01-15 2012-09-10 Закрытое акционерное общество "Научно-исследовательский институт "Аджиномото-Генетика" (ЗАО АГРИ) Способ получения l-аминокислот с использованием бактерий семейства enterobacteriaceae
US8940861B2 (en) 2010-04-08 2015-01-27 Georgia Tech Research Corporation Variants of ancestral uricases and uses thereof
CN102634492B (zh) 2011-02-14 2015-06-10 重庆富进生物医药有限公司 聚乙二醇化犬源尿酸氧化酶类似物及其制备方法和应用
CN102757945B (zh) * 2011-04-28 2015-03-18 杭州俊丰生物工程有限公司 人尿酸氧化酶蛋白及其制备方法和其聚乙二醇结合物
CN102260653B (zh) * 2011-06-30 2013-04-03 荣俊 一种peg化重组猪-人尿酸氧化酶融合蛋白的制备及应用方法
WO2014170916A2 (en) * 2013-04-17 2014-10-23 Council Of Scientific & Industrial Research Novel uricase mutants
CN103834623B (zh) * 2014-02-11 2017-11-07 中国药科大学 具有催化活性的人源尿酸氧化酶
CN104388467A (zh) * 2014-10-27 2015-03-04 李长贵 一种构建自发性高尿酸血症小鼠模型的方法及其用途
AU2016265677B2 (en) 2015-05-15 2021-12-09 Medimmune, Llc Improved uricase sequences and methods of treatment
CN106554948B (zh) 2015-09-29 2019-06-25 上海生物制品研究所有限责任公司 突变型尿酸酶、peg修饰的突变型尿酸酶及其应用
EP3538135A4 (de) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC Kombinationstherapien von prednison- und uricase-molekülen und deren verwendung
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
CN108103079B (zh) * 2017-06-20 2021-07-13 北京锦篮基因科技有限公司 一种高尿酸血症的基因治疗药物
CN109554376B (zh) * 2018-11-13 2022-03-22 广西大学 一种碱性尿酸氧化酶及其在检测试剂盒和降低食品中尿酸的应用
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
CN111088268B (zh) * 2019-03-05 2022-08-02 北京锦篮基因科技有限公司 一种高尿酸血症的基因治疗药物
AU2020276510B2 (en) 2019-05-10 2024-08-01 Hangzhou Grand Biologic Pharmaceutical Inc. Polyethylene glycol-modified urate oxidase
CN112646790A (zh) * 2019-10-11 2021-04-13 上海君实生物医药科技股份有限公司 改进的尿酸酶及其用于治疗高尿酸血症的方法
AU2021324665A1 (en) * 2020-08-10 2023-04-13 Horizon Therapeutics Usa, Inc. Methods of treating gout
CN111920942A (zh) * 2020-08-24 2020-11-13 深圳前海鹰岗生物科技有限公司 一种用于快速溶解痛风石的聚合物微针及制备方法和应用
CN117098559A (zh) * 2020-11-03 2023-11-21 波塔力克斯有限公司 修饰的尿酸酶及其用途
CN114438048B (zh) 2020-11-05 2024-10-22 重庆派金生物科技有限公司 尿酸氧化酶制剂及其应用
CN114438047B (zh) 2020-11-05 2024-11-22 重庆派金生物科技有限公司 制备聚乙二醇修饰的尿酸氧化酶的方法
CN112852772A (zh) * 2021-01-19 2021-05-28 中国科学院过程工程研究所 一种基于分子内交联和聚乙二醇修饰的尿酸氧化酶及其制备方法
CN112662640A (zh) * 2021-01-28 2021-04-16 中国药科大学 一种具有催化活性的尿酸氧化酶
CN113244412B (zh) * 2021-06-25 2021-10-26 深圳市瑞吉生物科技有限公司 一种基于mRNA剂型的治疗高尿酸血症或痛风的药物及其制备方法
AU2022340814A1 (en) * 2021-09-01 2024-02-15 Ginkgo Bioworks, Inc. Recombinant cells for treating diseases associated with uric acid and methods of use thereof
CN119343153A (zh) * 2022-12-27 2025-01-21 北京炫景瑞医药科技有限公司 一种治疗高尿酸相关疾病的核酸药物及其制备方法和用途
CN118360300A (zh) * 2023-01-10 2024-07-19 优环(苏州)生物医药科技有限公司 一种表达尿酸氧化酶的环状rna、制备方法及应用
CN119215150A (zh) 2023-06-28 2024-12-31 杭州远大生物制药有限公司 尿酸氧化酶及其聚乙二醇化缀合物的稳定剂及其药物用途
WO2025030053A1 (en) 2023-08-01 2025-02-06 Insmed Incorporated Novel igg proteases and methods of use thereof
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers
CN119876069B (zh) * 2025-03-12 2025-10-21 开平牵牛生化制药有限公司 具有高活性且免疫原性弱化的人源尿酸氧化酶突变体
CN120005844B (zh) * 2025-04-22 2025-09-23 天津科技大学 人源尿酸氧化酶突变体及其制备方法与应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE279486C (de)
US3613231A (en) 1969-07-25 1971-10-19 Paul F Pugh Method for manufacturing high voltage cable systems
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
DE3126759A1 (de) 1981-07-07 1983-01-27 Boehringer Mannheim Gmbh, 6800 Mannheim Loesliche leber-uricase, verfahren zu ihrer herstellung und verwendung
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4847325A (en) 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5075216A (en) 1988-09-23 1991-12-24 Cetus Corporation Methods for dna sequencing with thermus aquaticus dna polymerase
US5349052A (en) 1988-10-20 1994-09-20 Royal Free Hospital School Of Medicine Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5382518A (en) 1989-07-13 1995-01-17 Sanofi Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells
US5286637A (en) 1989-08-07 1994-02-15 Debiopharm, S.A. Biologically active drug polymer derivatives and method for preparing same
US5653974A (en) 1990-10-18 1997-08-05 Board Of Regents,The University Of Texas System Preparation and characterization of liposomal formulations of tumor necrosis factor
WO1994019007A1 (en) 1993-02-16 1994-09-01 Enzon, Inc. Ribosome inactivating protein compositions having reduced antigenicity
WO1995000162A1 (en) 1993-06-21 1995-01-05 Enzon, Inc. Site specific synthesis of conjugated peptides
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
AU697440B2 (en) 1994-12-07 1998-10-08 Novozymes A/S Polypeptide with reduced allergenicity
JPH09154581A (ja) 1995-12-05 1997-06-17 Asahi Chem Ind Co Ltd ウリカーゼを生産する実質上純粋な微生物
JP2001511162A (ja) 1997-02-06 2001-08-07 ノボ ノルディスク アクティーゼルスカブ 付加され、そして／又は除去された付着基を有するポリペプチド−ポリマー結合体
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
CA2337967C (en) * 1998-08-06 2011-11-01 Duke University Recombinant uricase protein
EP1100542B1 (de) 1998-08-06 2005-06-22 Mountain View Pharmaceuticals, Inc. Peg-uricase konjugate und verwendung davon
EP2158923B1 (de) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-uricase Konjugate und Verwendung davon

Also Published As

Publication number Publication date
JP2010158244A (ja) 2010-07-22
AU766421B2 (en) 2003-10-16
RU2290439C2 (ru) 2006-12-27
ZA200100974B (en) 2002-06-26
IL197339A (en) 2015-02-26
WO2000008196A9 (en) 2000-07-13
CN1322243A (zh) 2001-11-14
JP5721954B2 (ja) 2015-05-20
EP2277998B1 (de) 2016-04-20
KR20010053633A (ko) 2001-06-25
HUP0103205A3 (en) 2006-01-30
BR9913360A (pt) 2001-07-03
HK1037214A1 (en) 2002-02-01
IL141221A (en) 2010-06-16
HK1125402A1 (en) 2009-08-07
CA2337967A1 (en) 2000-02-17
ATE483797T1 (de) 2010-10-15
EP1100880A2 (de) 2001-05-23
CY1111001T1 (el) 2015-06-11
CN101280293A (zh) 2008-10-08
BRPI9913360B8 (pt) 2021-05-25
WO2000008196A3 (en) 2000-03-30
CZ304223B6 (cs) 2014-01-15
PL207369B1 (pl) 2010-12-31
KR100841634B1 (ko) 2008-06-26
WO2000008196A2 (en) 2000-02-17
DE69942834D1 (de) 2010-11-18
CA2337967C (en) 2011-11-01
NZ509633A (en) 2003-04-29
EP2277998A1 (de) 2011-01-26
PT1100880E (pt) 2011-01-13
EP1100880A4 (de) 2002-04-17
CN101280293B (zh) 2013-09-11
CZ2001466A3 (cs) 2001-07-11
ES2352451T3 (es) 2011-02-18
DK1100880T3 (da) 2011-01-24
BR9913360B1 (pt) 2013-09-24
EP1100880B1 (de) 2010-10-06
JP2002524053A (ja) 2002-08-06
JP2013215199A (ja) 2013-10-24
PL346222A1 (en) 2002-01-28
HU229774B1 (en) 2014-07-28
HUP0103205A2 (hu) 2001-12-28
IL197339A0 (en) 2011-07-31
AU5336599A (en) 2000-02-28
US7056713B1 (en) 2006-06-06
HK1153508A1 (en) 2012-03-30

Similar Documents

Publication Publication Date Title
PL346222A1 (en) Urate oxidase
ATE319854T1 (de) Enzymaktive dna moleküle
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
WO2001029222A3 (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
WO2000012726A3 (en) Rationally designed heparinases derived from heparinase i and ii
AU5850999A (en) Fungal transcriptional activator useful in methods for producing polypeptides
AUPO156596A0 (en) Synthetic polynucleotides
WO2001098469A3 (en) Polypeptides having peroxidase activity and nucleic acids encoding same
WO2000028043A3 (en) Polypeptides having lactonohydrolase activity and nucleic acids encoding same
AU5727099A (en) A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2000058352A3 (en) Barley gene for thioredoxin and nadp-thioredoxin reductase
WO2000041509A3 (en) Polypeptides having acid phosphatase activity and nucleic acids encoding same
AU2002346803A1 (en) Genes encoding for carbon metabolism and energy-producing proteins
WO2002062964A3 (en) Ap1 amine oxidase variants
WO1997029194A3 (de) Herstellung von l-ascorbinsäure
EP1383875A4 (de) Isolierte humane nadph-oxidase, nukleinsäuremoleküle, die für diese proteine codieren, und deren verwendungen
WO2001016325A3 (en) Plant reproduction proteins
WO2005003289A8 (en) Ap1 amine oxidase variants
EP1383871A4 (de) Isolierte menschliche enzymproteine, menschliche enzymproteine codierende nukleinsäuremoleküle sowie verwendungen davon
AU2002356494A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002254438A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002250346A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
WO2002038765A3 (en) Dna encoding bovine immunoglobulin a inducing protein and uses therefor
WO2000031241A3 (en) Polypeptides having choline oxidase activity and nucleic acids encoding same